Estimaciones de analistas de Wall Street para Aethlon Medical, Inc. (AEMD): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 1 |
| Mantener | 2 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 3 |
| Calificación media (1-5) | 0.33 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-11 | $-2.91 | ||
| 2026-08-13 | $-4.02 | $-3.92 | -2.6% |
| 2026-06-10 | $20.40 | $-12.30 | +265.9% |
| 2026-02-12 | $-12.25 | $-10.05 | -21.9% |
| 2025-11-12 | $-18.70 | $-8.50 | -120.0% |
| 2025-08-13 | $-42.50 | $-34.00 | -25.0% |
| 2025-06-26 | $-161.00 | $-4.90 | -3185.7% |
| 2025-02-12 | $-52.00 | $-88.00 | +40.9% |
Ratios de valoración
| Precio / Valor contable | 0.09 |
| EV / EBITDA | 0.55 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $392073 | $149625 | $229625 | $650187 | $659104 | $294165 | $574245 | 0 | 0 | 0 |
| Coste de Ventas | 0 | $2.63B | $3.08B | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$3.09B | -$2.49B | -$2.85B | $650187 | $659104 | $294165 | $574245 | 0 | 0 | 0 |
| I+D | $673000 | $586000 | $896000 | $927000 | $2.1M | $2.3M | $2.7M | $2.5M | $2.2M | $1.9M |
| Generales y Administrativos | $6.5M | $5.0M | $6.2M | $6.6M | $8.6M | $10.7M | $12.5M | $12.6M | $9.3M | $7.3M |
| Gastos Operativos | $6.5M | $5.0M | $6.2M | $6.6M | $8.6M | $10.7M | $12.5M | $12.6M | $9.3M | $7.3M |
| Beneficio Operativo | -$6.1M | -$4.8M | -$6.0M | -$5.9M | -$7.9M | -$10.4M | -$11.9M | -$12.6M | -$9.3M | -$7.3M |
| EBITDA | -$7.0M | -$5.3M | -$6.0M | -$5.9M | -$7.9M | -$10.3M | -$11.8M | -$11.8M | -$13.0M | -$6.8M |
| Gastos por Intereses | $304330 | $361597 | $220487 | $54232 | $1580 | 0 | 0 | 0 | $10109 | $14372 |
| Beneficio Antes de Impuestos | -$7.3M | -$5.7M | -$6.2M | -$6.4M | -$7.9M | -$10.4M | -$12.0M | -$12.2M | -$13.4M | -$7.2M |
| Impuestos | 0 | 0 | -$24785 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$7.3M | -$5.7M | -$6.2M | -$6.4M | -$7.9M | -$10.4M | -$12.0M | -$12.2M | -$13.4M | -$7.2M |
| BPA | $0.00 | $0.00 | $0.00 | $0.00 | $-521.81 | $-564.68 | $-468.60 | $-388.67 | $-85.77 | $-10.61 |
| BPA Diluido | $0.00 | $0.00 | $0.00 | $0.00 | $-521.81 | $-564.68 | $-468.60 | $-388.67 | $-85.77 | $-10.61 |
| Acciones en Circulación (Diluidas) | 0 | 0 | 0 | 0 | $15114 | $18446 | $25672 | $31410 | $156085 | $673945 |
Precio
| Precio | $1.43 |
| Capitalización | $1M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ADAP · ALUR · CODX · ERNA · IINN · LNAI · NVNO
Explorar sector: Healthcare · Medical - Devices
Más secciones de AEMD: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones